HomeIKT • NASDAQ
add
Inhibikase Therapeutics Inc
Previous close
$2.36
Day range
$2.39 - $2.60
Year range
$0.85 - $3.82
Market cap
169.68M USD
Avg Volume
325.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.64M | 0.91% |
Net income | -5.78M | -25.74% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -5.82M | -22.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.24M | -80.73% |
Total assets | 4.38M | -75.52% |
Total liabilities | 4.91M | 71.42% |
Total equity | -530.59K | — |
Shares outstanding | 67.19M | — |
Price to book | -33.71 | — |
Return on assets | -220.68% | — |
Return on capital | -567.09% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -5.78M | -25.74% |
Cash from operations | -4.88M | -18.90% |
Cash from investing | 2.53M | -85.19% |
Cash from financing | 181.95K | 259,834.29% |
Net change in cash | -2.17M | -116.77% |
Free cash flow | -2.46M | 2.04% |
About
Founded
2008
Headquarters
Website
Employees
8
